The Food and Drug Administration (FDA) is requiring a black box warning for benzodiazepines, which is warranted for some reasons but could cause unintended consequences, Matthew E. Hirschtritt, M.D., M.P.H., from California has warned. In addition to the new black box, which would ...
US market, 38% of which have received BBWs, and most of the antiseizure medications with BBWs are older-generation drugs. Some antiseizure medications have multiple BBWs; for example, valproic acid has three BBWs including hepatotoxicity, fetal risk, and pancreatitis, carbamazepine has BBWs of...
boxed (black box) warningFDAoverusewithdrawalWhat is known and Objective: The United States Food and Drug Administration (FDA) recently issued a Drug Safety Communication requiring Boxed Warning updating and other changes in order to improve the safe use of the benzodiazepine drug class. These ...
FDA requires black box warnings for combining benzodiazepines and opioidsThe Food and Drug Administration announced late last month that it would require classwide changes to labeling of benzodiazepines and certain opioids, including cough products containing opioids. The move is in response to the ...
Health officials call on FDA to put black-box warnings on benzodiazepines and opioidsNo abstract is available for this article.doi:10.1002/adaw.30516KnopfAlisonJohn Wiley & Sons, Ltd.Alcoholism & Drug Abuse Weekly
Multivariate logistic regression in the main sample showed a greater likelihood of individuals receiving anti-dementia medications (Odds Ratio, OR= 1.976, p= 0.0195) and benzodiazepines (OR=3.046, p= 0.0227) in the post-warning period as compared to the pre-warning period. Similarly, dementia ...